Innovator IBD 50 ETF (FFTY): Price and Financial Metrics ETF
FFTY Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $28.24 | 52-week high | $34.26 |
| Prev. close | $27.72 | 52-week low | $22.91 |
| Day low | $27.81 | Volume | 78,600 |
| Day high | $28.73 | Avg. volume | 130,302 |
| 50-day MA | $26.87 | Dividend yield | 0.93% |
| 200-day MA | $28.01 |
FFTY Stock Price Chart Interactive Chart >
Innovator IBD 50 ETF (FFTY) ETF Bio
The investment objective of the Innovator IBD 50 ETF seeks long-term capital appreciation. The fund selects its components from the stocks included in the growth-oriented IBD 50 Index and re-weighting them using a proprietary ranking system.
FFTY ETF Info
| Issuer | Innovator Capital Management |
| Expense Ratio | 0.8% |
| Underlying Index | IBD 50 Index |
| Asset Class | Equity |
| Sector | Managed ETFs |
| Assets Under Management (AUM) | 62.33K |
| Net Asset Value (NAV) | $27.70 |
| Options? | Yes |
| Total Holdings | 53 |
FFTY Top Holdings
| Symbol | Company | % of Total |
| DAVE | Dave Inc | 4.7% |
| AXON | Axon Enterprise Inc | 3.82% |
| AGX | Argan Inc | 3.81% |
| DUOL | Duolingo Inc | 3.78% |
| LRN | Stride Inc | 3.75% |
| RKLB | Rocket Lab USA Inc | 3.61% |
| ROOT | Root Inc/OH | 3.45% |
| PLTR | Palantir Technologies Inc | 3.43% |
| TVTX | Travere Therapeutics Inc | 3.35% |
FFTY Price Returns
| 1-mo | 9.76% |
| 3-mo | -11.72% |
| 6-mo | -1.12% |
| 1-year | 4.67% |
| 3-year | -3.13% |
| 5-year | -4.73% |
| YTD | -1.22% |
| 2024 | 18.36% |
| 2023 | 12.40% |
| 2022 | -51.08% |
| 2021 | 11.92% |
| 2020 | 18.20% |
FFTY Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||